Search Results

August 2022 Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi "San Francisco and Shanghai – August 1, 2022 – Structure Therapeutics Inc (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an oversubscribed In addition, Structure Therapeutics has completed dosing in a single ascending dose (SAD) Phase 1 study

Strong GPCR drug discovery decisions are built on structure, early risk awareness, and focused signal This week’s issue focuses on structure, early safety strategy, and the next wave of signal transduction GPCR University has undergone a structural redesign. Align your team around structured learning outcomes, not scattered slide decks. It is structured access and structured education.

Structured continuity.   explores the open-access 7TMR-Raft database cataloguing GPCR–lipid raft associations and the expanding therapeutic It is structured access to a field. It supports scientists refining expertise. Structured access creates momentum. Premium delivers that — consistently. Join Dr. GPCR Premium — Build Your Structured Advantage ➤

This conversation covers thermostabilization, cryoEM, and GPCR structural biology. << Back to podcast list Strategic Partner(s) Chris Tate: Thermostabilizing GPCRs for Structural Biology For most of the 1990s and early 2000s, GPCR structural biology was not a biology problem - it was a stability problem GPCR structures is no longer the limiting step in drug discovery. to arrestin and also the first structure of a Class D receptor.

Joseph Kim exploring GPCR structural biology, cryo-electron microscopy, opioid receptor pharmacology, Joseph Kim is a structural biologist studying membrane proteins and GPCR pharmacology. molecular structures inform the design and development of new therapeutics. GPCR Drug Discovery Is Increasingly Structural Modern GPCR drug discovery increasingly integrates structural You could easily imagine separate therapeutic programs targeting those different physiological effects

optimize the design and engineering of more efficacious therapeutics. perspective in the pursuit of receptor subtype-specific ligands, a major aspect to achieve safer, on-target therapeutics The Sunahara lab has also been developing protein-based therapeutics using structure-guided design and A notable therapeutic is an enzyme that hydrolyzes cocaine. as a treatment for cocaine abuse, a debilitating disease that would require long-term and sustained therapeutic